Amanote Research
Register
Sign In
482. Bid Is a Key Factor for Eliciting the Antiproliferative Activity of IFN-aL Mediated by TRAIL
Molecular Therapy
- United States
doi 10.1016/s1525-0016(16)37923-0
Full Text
Open PDF
Abstract
Available in
full text
Categories
Molecular Medicine
Molecular Biology
Pharmacology
Medicine
Genetics
Drug Discovery
Date
May 1, 2010
Authors
Unknown
Publisher
Elsevier BV
Related search
C-CBL-Mediated Degradation of TRAIL Receptors Is Responsible for the Development of the Early Phase of TRAIL Resistance
Cellular Signalling
Cell Biology
MyD88-Dependent IFN- Production by NK Cells Is Key for Control of Legionella Pneumophila Infection
Journal of Immunology
Allergy
Immunology
The IFN- -Dependent Suppressor of Cytokine Signaling 1 Promoter Activity Is Positively Regulated by IFN Regulatory Factor-1 and Sp1 but Repressed by Growth Factor Independence-1b and Kruppel-Like Factor-4, and It Is Dysregulated in Psoriatic Keratinocytes
Journal of Immunology
Allergy
Immunology
Synergistic Antiproliferative Activity of Tamoxifen and Docetaxel on Three Oestrogen Receptor-Negative Cancer Cell Lines Is Mediated by the Induction of Apoptosis
British Journal of Cancer
Cancer Research
Oncology
Induction of HSP70 Gene Expression by the Antiproliferative Prostaglandin PGA2: A Growth-Dependent Response Mediated by Activation of Heat Shock Transcription Factor.
Molecular and Cellular Biology
Cell Biology
Molecular Biology
Neuroprotective Effect of Orexin-A Is Mediated by an Increase of Hypoxia-Inducible Factor-1 Activity in Rat
Anesthesiology
Anesthesiology
Pain Medicine
P53 Is Necessary for the Apoptotic Response Mediated by a Transient Increase of Ras Activity
Molecular and Cellular Biology
Cell Biology
Molecular Biology
ETS-1 Oncogenic Activity Mediated by Transforming Growth Factor
Cancer Research
Cancer Research
Oncology
IFN- -Mediated Downregulation of LXA4 Is Necessary for the Maintenance of Nonresolving Inflammation and Papilloma Persistence
Cancer Research
Cancer Research
Oncology
